John Walsh analyst

Currently out of the existing stock ratings of John Walsh, 121 are a HOLD (35.91%), 194 are a BUY (57.57%), 22 are a SELL (6.53%).

John Walsh

Work Performance Price Targets & Ratings Chart

Analyst John Walsh, has had 83.19% of price targets met with an average potential upside of 22.17%, reached in 491 days on average. Previously, John Walsh worked at CREDIT SUISSE, VERTICAL RESEARCH.

John Walsh has documented 675 price targets and ratings displayed on 42 stocks. The coverage was on Industrials, Technology, Basic Materials, Healthcare, Utilities sectors.

Most recent stock forecast was given on DD, Dupont De Nemours at 09-Nov-2022.

Wall Street Analyst John Walsh

Analyst best performing recommendations are on GTLS (CHART INDUSTRIES).
The best stock recommendation documented was for GTLS (CHART INDUSTRIES) on 10/13/2020. The price target of $80 was fulfilled within 1 day with a profit of $4.69 (6.23%), with a performance score of 62.28.

Average potential price target upside

ALLE Allegion PLC ANSS ANSYS AQUA Evoqua Water Technologies ATKR Atkore International Group AYI Acuity Brands CARR Carrier Global Corp EMR Emerson Electric Company ETN Eaton PLC FLS Flowserve FTV Fortive Corp GE General Electric Company GTLS Chart Industries HON Honeywell International IR Ingersoll Rand JCI Johnson Controls International PLC LII Lennox International MMM 3M Company MTTR Matterport OTIS Otis Worldwide Corp ROK Rockwell Automation TT Trane Technologies plc VNT Vontier Corp XYL Xylem DD Dupont De Nemours BGRY Berkshire Grey STRC Sarcos Technology and Robotics GDI Ingersoll Rand ZWS Zurn Elkay Water Solutions

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-Sep-2020

$181

$-2.61 (-1.42%)

$142

18 days ago
(03-Nov-2026)

9/10 (90%)

$-8.35 (-4.41%)

191

Buy Since 07-Apr-2022

$206

$22.39 (12.19%)

$198

26 days ago
(26-Oct-2026)

9/11 (81.82%)

$27.78 (15.59%)

554

Hold Since 01-Oct-2025

$183

$-0.61 (-0.33%)

$161

29 days ago
(23-Oct-2026)

36/37 (97.3%)

$4.02 (2.25%)

311

Hold Since 29-Apr-2026

$200

$16.39 (8.93%)

$150

29 days ago
(23-Oct-2026)

1/2 (50%)

$21.02 (11.74%)

85

Hold Since 24-Jul-2026

$170

$-13.61 (-7.41%)

$150

3 months 28 days ago
(24-Jul-2026)

6/6 (100%)

$17.18 (11.24%)

175

Show more analysts

Stocks John Walsh covered previously. Scores are shown for active stocks only.

CRIS Curis CTSO Cytosorbents Crp DDD 3D Systems FUSN Fusion Pharmaceuticals GD General Dynamics HROW Harrow Health LNTH Lantheus Holdings MT ArcelorMittal SA ADR PNT POINT Biopharma Global RXN Rexnord SNDX Syndax Pharmaceuticals THTX Theratechnologies VOR Vor Biopharma VRAY ViewRay

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?